BackFidelity Select Portfolios - Medical Technology and Devices Portfolio Overview
Fidelity Select Portfolios - Medical Technology and Devices Portfolio

Fidelity Select Portfolios - Medical Technology and Devices Portfolio Return on Equity

Latest ROE for Fidelity Select Portfolios - Medical Technology and Devices Portfolio: -7.73% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-7.73%

Return on Equity

-7.73%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Fidelity Select Portfolios - Medical Technology and Devices Portfolio (FSMEX) FAQ

The latest ROE for FSMEX is -7.73%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Fidelity Select Portfolios - Medical Technology and Devices Portfolio's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, FSMEX currently prints -7.73% for ROE, while the sector average sits near 11.3%. That is roughly 168.4% below the sector mean. Large gaps often invite a closer look at Fidelity Select Portfolios - Medical Technology and Devices Portfolio's growth, margins, and balance sheet.

Return on Equity shows how effectively Fidelity Select Portfolios - Medical Technology and Devices Portfolio converts resources into returns. At -7.73%, FSMEX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting FSMEX's ROE (-7.73%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.